Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1
Clinical trial NCT01524575 · WITHDRAWN
Trial details
- NCT number
- NCT01524575
- Sponsor
- University of Hawaii
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.